Home > Insider Trading > West Pharmaceutical Services Inc

West Pharmaceutical Services Inc (WST)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

1 - 10
Next >>

West Pharmaceutical Services (WST) Fell Due to Lower-Than-Expected Results and Reduced Guidance

Baron Funds, an investment management company, released its “Baron Asset Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here.

Keep Reading →

October 30th, 2024 - Hedge Fund Investor Letters News

West Pharmaceutical Services, Inc. (NYSE:WST) Q3 2024 Earnings Call Transcript

West Pharmaceutical Services, Inc. (NYSE:WST) Q3 2024 Earnings Call Transcript October 24, 2024West Pharmaceutical Services, Inc. beats earnings expectations.

Keep Reading →

October 25th, 2024 - News Transcripts

West Pharmaceuticals (WST) Fell Due to Industry Headwinds

Conestoga Capital Advisors, an asset management company, released its third-quarter 2024 investor letter. A copy of the letter can be downloaded here.

Keep Reading →

October 22nd, 2024 - Hedge Fund Investor Letters News

Should You Hold West Pharmaceutical Services (WST) for the Long Term?

Conestoga Capital Advisors, an asset management company, released its “Mid-Cap Strategy” second-quarter 2024 investor letter. A copy of the letter can be downloaded here.

Keep Reading →

August 19th, 2024 - Hedge Fund Investor Letters News

West Pharmaceutical Services, Inc. (NYSE:WST) Q2 2024 Earnings Call Transcript

West Pharmaceutical Services, Inc. (NYSE:WST) Q2 2024 Earnings Call Transcript July 25, 2024West Pharmaceutical Services, Inc. misses on earnings expectations.

Keep Reading →

July 26th, 2024 - News Transcripts

Does West Pharmaceutical Services (WST) Have Attractive Growth Drivers?

Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here.

Keep Reading →

July 17th, 2024 - Hedge Fund Investor Letters News

25 Best Dividend Aristocrats to Buy According to Analysts

The age-old debate of investing in dividend growth or high-yield stocks continues to reappear within the dividend investing realm.

Keep Reading →

June 6th, 2024 - Dividend Stocks Hedge Funds News

Here’s Why West Pharmaceutical Services (WST) Bounced Back in Q1

Conestoga Capital Advisors, an asset management company, released its “Mid-Cap Strategy” first-quarter 2024 investor letter. A copy of the letter can be downloaded here.

Keep Reading →

May 24th, 2024 - Hedge Fund Investor Letters News

West Pharmaceutical Services, Inc. (NYSE:WST) Q1 2024 Earnings Call Transcript

West Pharmaceutical Services, Inc. beats earnings expectations. Reported EPS is $1.56, expectations were $1.26. West Pharmaceutical Services, Inc.

Keep Reading →

April 30th, 2024 - News Transcripts

What Makes West Pharmaceutical Services (WST) an Attractive Bet?

ClearBridge Investments, an investment management firm, released its fourth-quarter 2023 “Mid Cap Growth Strategy” investor letter, a copy of which can be downloaded here.

Keep Reading →

April 1st, 2024 - Hedge Fund Investor Letters News